Opus Genetics, Inc. (IRD) Misses Q1 EPS by 62c

Opus Genetics, Inc. (NASDAQ: IRD) reported Q1 EPS of ($0.75), $0.62 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $2.16 million versus the consensus estimate of $3.16 million.

For earnings history and earnings-related data on Opus Genetics, Inc. (IRD) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• Nomura/Instinet Upgrades MR DIY Group M Bhd (MRDIY:MK) to Buy
• RBC Capital Downgrades Spire Healthcare (SPI:LN) (SRRHF) to Sector Perform